{"article_title": "We're Now In Pharma's 'Top Tier'", "article_keywords": ["tier", "pharmas"], "article_url": "http://www.forbes.com/sites/brucejapsen/2015/04/23/abbvies-ceo-gonzalez-were-now-in-pharmas-top-tier/", "article_text": "", "article_metadata": {"description": "Abbvie chief executive Rick Gonzalez, whose team beat out several more established drug giants in the successful bid for cancer pill maker Pharmacyclics, said today new and existing products will bring \u201ctop tier growth through the rest of the decade and beyond.\u201d Gonzalez\u2019 bold statement, setting the stage for a larger [...]", "author": "Bruce Japsen", "og": {"site_name": "Forbes", "description": "Abbvie chief executive Rick Gonzalez, whose team beat out several more established drug giants in the successful bid for cancer pill maker Pharmacyclics, said today new and existing products will bring \u201ctop tier growth through the rest of the decade and beyond.\u201d Gonzalez\u2019 bold statement, setting the stage for a larger [...]", "title": "Abbvie's CEO Gonzalez: We're Now In Pharma's 'Top Tier'", "url": "http://www.forbes.com/sites/brucejapsen/2015/04/23/abbvies-ceo-gonzalez-were-now-in-pharmas-top-tier/", "image": "http://blogs-images.forbes.com/brucejapsen/files/2013/01/Rick0111-e1429800779986-1940x1841.jpg", "updated_time": "2015-04-23T13:06:27-04:00", "type": "article"}, "twitter": {"description": "Abbvie chief executive Rick Gonzalez, whose team beat out several more established drug giants in the successful bid for cancer pill maker Pharmacyclics, said today new and existing products will bring \u201ctop tier growth through the rest of the decade and beyond.\u201d Gonzalez\u2019 bold statement, setting the stage for a larger [...]", "creator": "@brucejapsen", "image": "http://blogs-images.forbes.com/brucejapsen/files/2013/01/Rick0111-e1429800779986-1940x1841.jpg", "title": "Abbvie's CEO Gonzalez: We're Now In Pharma's 'Top Tier'", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Health,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2015-04-23", "published": "2015-04-23", "id": "blogAndPostId/blog/post/2125-10818"}, "news_keywords": "Business,Health,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "article_summary": ""}